These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Gardier AM, Wurtman RJ. Brain Res; 1991 Feb 01; 540(1-2):325-30. PubMed ID: 1711396 [Abstract] [Full Text] [Related]
3. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats. Laferrere B, Wurtman RJ. Brain Res; 1989 Dec 18; 504(2):258-63. PubMed ID: 2480833 [Abstract] [Full Text] [Related]
4. Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release. Fuller RW, Snoddy HD, Robertson DW. Pharmacol Biochem Behav; 1988 Jul 18; 30(3):715-21. PubMed ID: 2463643 [Abstract] [Full Text] [Related]
5. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Series HG, Cowen PJ, Sharp T. Psychopharmacology (Berl); 1994 Dec 18; 116(4):508-14. PubMed ID: 7535469 [Abstract] [Full Text] [Related]
6. Effect of chronic D-fenfluramine administration on rat hypothalamic serotonin levels and release. Schaechter JD, Wurtman RJ. Life Sci; 1989 Dec 18; 44(4):265-71. PubMed ID: 2464733 [Abstract] [Full Text] [Related]
7. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Gardier AM, Kaakkola S, Erfurth A, Wurtman RJ. Brain Res; 1992 Aug 14; 588(1):67-74. PubMed ID: 1382807 [Abstract] [Full Text] [Related]
8. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine. Tao R, Fray A, Aspley S, Brammer R, Heal D, Auerbach S. Eur J Pharmacol; 2002 Jun 07; 445(1-2):69-81. PubMed ID: 12065196 [Abstract] [Full Text] [Related]
9. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Javed A, Van De Kar LD, Gray TS. Brain Res; 1997 Nov 07; 774(1-2):94-105. PubMed ID: 9452197 [Abstract] [Full Text] [Related]
10. Serotonergic regulation of acetylcholine release in rat frontal cortex. Hirano H, Day J, Fibiger HC. J Neurochem; 1995 Sep 07; 65(3):1139-45. PubMed ID: 7643092 [Abstract] [Full Text] [Related]
11. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan. Van de Kar LD, Urban JH, Richardson KD, Bethea CL. Neuroendocrinology; 1985 Oct 07; 41(4):283-8. PubMed ID: 2931613 [Abstract] [Full Text] [Related]
14. Isolation rearing of rats alters release of 5-hydroxytryptamine and dopamine in the frontal cortex: an in vivo electrochemical study. Crespi F, Wright IK, Möbius C. Exp Brain Res; 1992 Oct 07; 88(3):495-501. PubMed ID: 1375164 [Abstract] [Full Text] [Related]
15. Prolactin response to fenfluramine is independent of serotonin release. McCann UD, Hatzidimitriou G, Ricaurte GA. Eur J Pharmacol; 1996 Sep 26; 312(2):R1-2. PubMed ID: 8894606 [Abstract] [Full Text] [Related]
16. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Sabol KE, Richards JB, Seiden LS. Brain Res; 1992 Jul 10; 585(1-2):421-4. PubMed ID: 1511330 [Abstract] [Full Text] [Related]
19. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. Raiteri M, Bonanno G, Vallebuona F. J Pharmacol Exp Ther; 1995 May 10; 273(2):643-9. PubMed ID: 7752066 [Abstract] [Full Text] [Related]